SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-245701
Filing Date
2024-10-28
Accepted
2024-10-28 17:29:22
Documents
11
Effectiveness Date
2024-10-28

Document Format Files

Seq Description Document Type Size
1 S-3ASR d900457ds3asr.htm S-3ASR 325818
2 EX-4.3 d900457dex43.htm EX-4.3 299041
3 EX-4.6 d900457dex46.htm EX-4.6 95232
4 EX-4.7 d900457dex47.htm EX-4.7 95503
5 EX-4.8 d900457dex48.htm EX-4.8 84362
6 EX-5.1 d900457dex51.htm EX-5.1 23877
7 EX-23.1 d900457dex231.htm EX-23.1 3663
8 EX-FILING FEES d900457dexfilingfees.htm EX-FILING FEES 31914
9 GRAPHIC g900457dsp02.jpg GRAPHIC 10914
10 GRAPHIC g900457dsp06.jpg GRAPHIC 8544
11 GRAPHIC g900457g00g03.jpg GRAPHIC 52420
  Complete submission text file 0001193125-24-245701.txt   1059788
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-282861 | Film No.: 241402050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)